Latest information on COVID-19
Support teaching, research, and patient care.
Tara Chang, MD, MS is a board-certified nephrologist who enjoys taking care of patients with all types of kidney diseases. She is also a certified Hypertension Specialist, and has a particular interest in treating patients with high blood pressure. In addition to her patient care duties, Dr. Chang maintains an active clinical research program, which focuses on studying cardiovascular disease in patients with chronic kidney disease. She has received grant funding from the National Institutes of Health and the American Heart Association. Dr. Chang speaks conversational Mandarin. She enjoys jogging, yoga, and spending time with her husband, son and twin daughters.
As a board-certified nephrologist, I see first-hand the pervasiveness of cardiovascular disease in patients with chronic kidney disease (CKD). As a trained epidemiologist and clinical researcher, I also see the lack of evidence available to guide treatment decision-making in CKD. Motivated by these evidence gaps, my research seeks to clarify questions about cardiovascular care in patients with CKD. My research specifically focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with CKD, with the long-term goal of improving outcomes in these high-risk patients.
Comparing Diuretic Strategies in Hospitalized Heart Failure
We will conduct a pragmatic randomized trial comparing whether using a combination of two
types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will
result in shorter hospital stays for patients hospitalized with heart failure.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
The objective of this study is to evaluate the safety and effectiveness of the MobiusHD
System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal